LAURA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
LAURA
Jun 24, 2024, 17:19 |
Blog
David R. Spigel commented on the major lung cancer research updates for Patient Power
Sarah Cannon Research Institute shared on LinkedIn: .…
Jun 23, 2024, 09:25 |
Insight
David R. Spigel comments on CROWN, LAURA, and ADRIATIC studies
Sarah Cannon Docs shared on X: ""It's just kind of blown everyone away that the…
Jun 10, 2024, 16:23 |
Blog
Laura Bobolts: Here are my top 3 studies from ASCO2024
Laura Bobolts, Senior Vice President, Clinical Strategy and Growth at OncoHealth, posted on LinkedIn: "ASCO2024 is…
Jun 5, 2024, 11:51 |
Blog
Patrick Forde: Initial thoughts I will bring back to clinic from ASCO24
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
Jun 5, 2024, 06:56 |
Blog
Estela Rodriguez: ASCO24 LAURA standing ovation
Estela Rodriguez shared on X/Twitter: "ASCO24 LAURA I’m putting this standing ovation video out here for…
Jun 4, 2024, 14:59 |
Societies
15 Posts From ASCO24 Day 4 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 4, 2024, 03:08 |
Societies
ASCO24 Day 3 Highlights by The Oncology Brothers
The Oncology Brothers shared on X: "1. DB06 TDxD HR+ metastatic breast cancer (mBC) 2.…
May 28, 2024, 08:21 |
Blog
Antonio Passaro's top 10 selection with explanation, among the lung cancer abstracts from ASCO24
Antonio Passaro, shared a post on X: ''ASCO24 is ready to start soon! Here, my top…
Apr 28, 2024, 11:04 |
Blog
Ana I. Velázquez Mañana: ASCO24 abstract titles are out! Exciting Plenary Session, specially for LCSM community
Ana I. Velázquez Mañana shared on X/Twitter: “ASCO24 abstract titles are out! Exciting Plenary Session, specially…
All:
9
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube